Skip to main content

News stories

Research patient recruitment reaches record high

Published on 03/07/2025

 Daniel Lenton, Portfolio Support Officer; Abi Roberts, Clinical Research  and Development Nurse; Heather Willis, Senior Clinical Research and Development Nurse; Asha  Clement, Clinical Research and Development Nurse
Daniel Lenton, Portfolio Support Officer; Abi Roberts, Clinical Research and Development Nurse; Heather Willis, Senior Clinical Research and Development Nurse; Asha Clement, Clinical Research and Development Nurse

The research team at Good Hope Hospital has marked a major milestone, achieving a remarkable 1000% increase in patient recruitment over the past six years.  

In 2019, there were just 50 patients recruited to research studies at the hospital. In 2024-2025, this has soared to an impressive 573, a testament to the hospital’s growing research capabilities. 

The expansion began in August 2019, when Good Hope Hospital appointed its first research nurse with a vision to build a diverse non-cancer research portfolio. At the time, the hospital had a limited research presence, with just 1.5 whole-time equivalent research nurses focusing solely on cancer studies. 

Since then, the team has grown to include three research nurses, Heather Willis, Abi Roberts and Asha Clement, and a portfolio support officer, Daniel Lenton. 

With an expanded team and a stronger research infrastructure, the hospital has developed a broad research portfolio, increasing opportunities for patient participation across various specialties. 

The team faced setbacks during the COVID-19 pandemic. The hospital rapidly set up COVID-related studies, which raised public awareness of research's importance. However, normal research portfolios were temporarily paused, and staff were redeployed. 

Since then, research activity has continued to thrive post-pandemic, and the team has been recognised by study sponsors for their high levels of recruitment. 

With research now a significant part of Good Hope Hospital’s long-term strategy, the team has ambitious plans, including creating a designated research facility on-site, developing a commercial research portfolio and ensuring research remains self-sustaining and not a cost burden. 

As the hospital moves forward with its strategy, its commitment to fostering a future-proof research workforce and expanding patient access to life-changing clinical studies remains key. 

More news

Review led by researchers highlights potential treatment for alcohol use disorder

Review led by researchers highlights potential treatment for alcohol use disorder

University Hospitals Birmingham colleagues are among the authors of an international research paper recently published in The Lancet. Led by Dr Pouya Ebrahimi, Specialty Registrar in Cardiology, and Dr Yash Kachela, Medical Student Undergraduate, the study examines how diabetes and weight management medicines may support people living with alcohol use disorder.
UHB leads initiative to improve understanding of treatment information needs

UHB leads initiative to improve understanding of treatment information needs

A new initiative aims to better understand the treatment information needs of people living with inherited bleeding disorders across the Midlands.
Birmingham researchers lead state-of-the-art review on heart disease in chronic kidney disease

Birmingham researchers lead state-of-the-art review on heart disease in chronic kidney disease

Researchers from University Hospitals Birmingham and the University of Birmingham have carried out a commissioned state-of-the-art review on heart disease in chronic kidney disease (CKD).
Read more news